Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension
Clinical Cardiology · 2026-11 · 49 (11)
DOI: 10.1002/clc.70503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 05.11.2026. Verfasst von Yijia Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Stroke Volume, Heart Failure, Pulmonary Embolism. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Chronic thromboembolic pulmonary hypertension (CTEPH) and left heart disease, particularly heart failure with preserved ejection fraction (HFpEF), show overlapping clinical features despite distinct pathophysiology.
Objectives
The HFpEF‐ABA algorithm (age, body mass index, atrial fibrillation) was used to characterize HFpEF pretest probability in patients with CTEPH and evaluate its association with left heart disease and clinical worsening.
Methods
Among 466 patients with CTEPH stratified by HFpEF‐ABA score (low < 25%, intermediate 25%–74%, high ≥ 75%), Spearman's correlation assessed associations with common left heart disease comorbidities. Kaplan‐Meier analysis and Cox regression evaluated associations with clinical worsening, with restricted cubic splines assessing the dose‐response relationship and non‐linearity. Subgroup analyses by sex, smoking, alcohol use, hypertension, coronary artery disease, and obstructive sleep apnea assessed the consistency. We also evaluated whether adding the HFpEF‐ABA score improved COMPERA 2.0 discrimination for clinical worsening.
Results
Intermediate and high HFpEF probability was found in 52.4% ( n = 244) and 9.0% ( n = 42), respectively. After adjustment, each standard deviation increase in HFpEF probability was associated with an approximately 73% increase in clinical worsening ( p < 0.001). Results were consistent for HFpEF probability ( p < 0.05), with no significant subgroup interactions. Adding HFpEF‐ABA with COMPERA 2.0 improved discrimination, increasing the C‐index increasing from 0.532 to 0.634 ( p = 0.012).
Conclusions
Assessing HFpEF probability in patients with CTEPH identifies those at high risk for this comorbidity and improves the precision when integrated with existing risk models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Tao Yang, Zhihong Liu
Förderung
- National High Level Hospital Clinical Research Funding
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- The Artificial Intelligence and Information Technology Application Fund of Fuwai Hospital, Chinese Academy of Medical Sciences
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation
Zitieren
APA
Wang, Y., Li, X., Huang, Z., Duan, A., Wang, Q., Gao, L., Li, S., Zhao, Q., Yang, T., Zhao, Z., Luo, Q., & Liu, Z. (2026). Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70503
Vancouver
Wang Y, Li X, Huang Z, Duan A, Wang Q, Gao L, et al. Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70503
BibTeX
@article{Wang2026,
author = {Wang, Yijia and Li, Xin and Huang, Zhihua and Duan, Anqi and Wang, Qi and Gao, Luyang and Li, Sicong and Zhao, Qing and Yang, Tao and Zhao, Zhihui and Luo, Qin and Liu, Zhihong},
title = {Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension},
journal = {Clinical Cardiology},
year = {2026},
volume = {49},
number = {11},
doi = {10.1002/clc.70503}
}
EUVIMED